Paper34608495
European expert consensus on improving patient selection for the management of disabling spasticity with intrathecal baclofen and/or botulinum toxin type A.
Biering-Soerensen B and 7 others. J Rehabil Med, 2022. Cited by 35 papers, by iCite.
Cite this record
ConductScience Library. European expert consensus on improving patient selection for the management of disabling spasticity with intrathecal baclofen and/or botulinum toxin type A. Papers, record 34608495. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34608495
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- European expert consensus on improving patient selection for the management of disabling spasticity with intrathecal baclofen and/or botulinum toxin type A.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Botulinum Toxins, Type A | Major topic |
| Muscle Relaxants, Central | Major topic |
| Adult | |
| Baclofen | |
| Humans | |
| Injections, Spinal | |
| Muscle Spasticity | |
| Patient Selection |
Source PubMed
References71
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20871140 | Clinical outcome and complications of intrathecal baclofen pump in multiple sclerosis patients: a retrospective study. | NeuroRehabilitation | 2010 | https://conductscience.org/library/papers/20871140 | PubMed |
| 2 | 30200281 | The Effect of Repeated Botulinum Toxin A Therapy Combined with Intensive Rehabilitation on Lower Limb Spasticity in Post-Stroke Patients. | Toxins (Basel) | 2018 | https://conductscience.org/library/papers/30200281 | PubMed |
| 3 | 27256591 | Effects of botulinum toxin A therapy and multidisciplinary rehabilitation on upper and lower limb spasticity in post-stroke patients. | Int J Neurosci | 2017 | https://conductscience.org/library/papers/27256591 | PubMed |
| 4 | 28914131 | Safety and Efficacy of Repeat Open-Label AbobotulinumtoxinA Treatment in Pediatric Cerebral Palsy. | J Child Neurol | 2017 | https://conductscience.org/library/papers/28914131 | PubMed |
| 5 | 31695821 | Identification of complications in paediatric cerebral palsy treated with intrathecal baclofen pump: a descriptive analysis of 15 years at one institution. | J Child Orthop | 2019 | https://conductscience.org/library/papers/31695821 | PubMed |
| 6 | 30264872 | Intrathecal baclofen in paroxysmal sympathetic hyperactivity: Impact on oral treatment. | Brain Behav | 2018 | https://conductscience.org/library/papers/30264872 | PubMed |
| 7 | 30366276 | Intrathecal baclofen for multiple sclerosis related spasticity: A twenty year experience. | Mult Scler Relat Disord | 2019 | https://conductscience.org/library/papers/30366276 | PubMed |
| 8 | 22104692 | Intrathecal baclofen therapy for severe spasticity: analysis on a series of 112 consecutive patients and future prospectives. | Clin Neurol Neurosurg | 2012 | https://conductscience.org/library/papers/22104692 | PubMed |
| 9 | 22955957 | Efficacy and safety of higher doses of botulinum toxin type A NT 201 free from complexing proteins in the upper and lower limb spasticity after stroke. | J Neural Transm (Vienna) | 2013 | https://conductscience.org/library/papers/22955957 | PubMed |
| 10 | 29326296 | Intrathecal baclofen therapy versus conventional medical management for severe poststroke spasticity: results from a multicentre, randomised, controlled, open-label trial (SISTERS). | J Neurol Neurosurg Psychiatry | 2018 | https://conductscience.org/library/papers/29326296 | PubMed |
| 11 | 17084128 | Intrathecal baclofen management of poststroke spastic hypertonia: implications for function and quality of life. | Arch Phys Med Rehabil | 2006 | https://conductscience.org/library/papers/17084128 | PubMed |
| 12 | 31717282 | The Effect of Botulinum Toxin Injections on Gross Motor Function for Lower Limb Spasticity in Children with Cerebral Palsy. | Toxins (Basel) | 2019 | https://conductscience.org/library/papers/31717282 | PubMed |
| 13 | 21707598 | Controlled study of the effects of continuous intrathecal baclofen infusion in non-ambulant children with cerebral palsy. | Dev Med Child Neurol | 2011 | https://conductscience.org/library/papers/21707598 | PubMed |
| 14 | 31469982 | Poststroke Postural Sway Improved by Botulinum Toxin: A Multicenter Randomized Double-blind Controlled Trial. | Arch Phys Med Rehabil | 2020 | https://conductscience.org/library/papers/31469982 | PubMed |
| 15 | 27282329 | Optimizing the Management of Disabling Spasticity Following Spinal Cord Damage: The Ability Network-An International Initiative. | Arch Phys Med Rehabil | 2016 | https://conductscience.org/library/papers/27282329 | PubMed |
| 16 | 31851884 | Intrathecal Baclofen Infusion Pumps in the Treatment of Spasticity: A Retrospective Cohort Study in a Portuguese Centre. | Acta Med Port | 2019 | https://conductscience.org/library/papers/31851884 | PubMed |
| 17 | 21992161 | Prospective 12-month study of intrathecal baclofen therapy for poststroke spastic upper and lower extremity motor control and functional improvement. | Neuromodulation | 2011 | https://conductscience.org/library/papers/21992161 | PubMed |
| 18 | 30354975 | Effect of Intrathecal Baclofen on Pain and Quality of Life in Poststroke Spasticity. | Stroke | 2018 | https://conductscience.org/library/papers/30354975 | PubMed |
| 19 | 19197564 | European consensus table on the use of botulinum toxin type A in adult spasticity. | J Rehabil Med | 2009 | https://conductscience.org/library/papers/19197564 | PubMed |
| 20 | 28283596 | Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study. | Neurology | 2017 | https://conductscience.org/library/papers/28283596 | PubMed |
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42211298 | Early recognition of post-stroke spasticity: the I-REFER study. | Front Neurol | 2026 | https://conductscience.org/library/papers/42211298 | PubMed |
| 41911102 | Radiosurgical Irradiation of Spinal Nerve Roots for the Management of Spasticity: A Systematic Review. | Stereotact Funct Neurosurg | 2026 | https://conductscience.org/library/papers/41911102 | PubMed |
| 41882905 | 2024 Japan Society for Stereotactic and Functional Neurosurgery Guidelines for Stereotactic and Functional Neurosurgery. | Neurol Med Chir (Tokyo) | 2026 | https://conductscience.org/library/papers/41882905 | PubMed |
| 41877991 | Relationships between arm and leg real-life activity and clinical assessments in individuals with disabling spasticity after stroke. | Front Stroke | 2026 | https://conductscience.org/library/papers/41877991 | PubMed |
| 41803279 | Wearable powered overground exoskeleton reduces dose-dependently the spasticity in individuals with spinal cord injury. | Spinal Cord | 2026 | https://conductscience.org/library/papers/41803279 | PubMed |
| 41714413 | A phenomenological approach to spastic movement disorders: an international expert panel consensus. | J Neurol | 2026 | https://conductscience.org/library/papers/41714413 | PubMed |
| 41591203 | Aligning Minds in Spasticity Care-A Two-Phase Delphi-Dialogue Study of Patients and Professionals in Spain. | Toxins (Basel) | 2026 | https://conductscience.org/library/papers/41591203 | PubMed |
| 41441609 | Artificial Intelligence in Managing Spasticity with Botulinum Toxin Type A-Insights from an Exploratory Pilot Investigation: The AIMS Study. | Toxins (Basel) | 2025 | https://conductscience.org/library/papers/41441609 | PubMed |
| 41432712 | Construction and verification of a nomogram model for predicting the risk of post-stroke spasticity: a retrospective study. | Ann Med | 2026 | https://conductscience.org/library/papers/41432712 | PubMed |
| 41065820 | Does preconditioning with serial casting prior to abobotulinumtoxinA injection improve outcomes in the rehabilitation of post-stroke wrist and finger flexor spasticity? | J Neural Transm (Vienna) | 2025 | https://conductscience.org/library/papers/41065820 | PubMed |
| 40947884 | The effect of short-term treatment with botulinum toxin a on muscle stiffness in stroke patients: an exploratory study. | J Rehabil Med | 2025 | https://conductscience.org/library/papers/40947884 | PubMed |
| 40864061 | Pathways for Diagnosis and Multimodal Management, Including Botulinum Neurotoxin Therapy, in Shoulder Conditions Following Acquired Central Nervous System Lesions. | Toxins (Basel) | 2025 | https://conductscience.org/library/papers/40864061 | PubMed |
| 40812740 | Pulmonary Function and Sleep-Related Disorders During Cervical Administration of Intrathecal Baclofen in Adults With Spinal Cord Injury (Cervit-B): Protocol for a Multiphase Single-Arm Intervention Trial. | JMIR Res Protoc | 2025 | https://conductscience.org/library/papers/40812740 | PubMed |
| 40557278 | Case Report: Lateral C1-C2 puncture for intrathecal baclofen therapy: an alternative effective and safe approach after spinal cord injury. | Front Pain Res (Lausanne) | 2025 | https://conductscience.org/library/papers/40557278 | PubMed |
| 40487150 | Conference Abstracts "Bridges in Rehabilitation" of the 2nd Physical Medicine and Rehabilitation Department, National Rehabilitation Center EKA (Ethniko Kentro Apokatastasis) 14-15 December 2024, National Rehabilitation Center EKA, Ilion, Athens, Greece. | J Frailty Sarcopenia Falls | 2025 | https://conductscience.org/library/papers/40487150 | PubMed |
| 40442021 | A Multicenter, Retrospective, Real-World Study of Treatment Outcomes Following on-label AbobotulinumtoxinA Injections for Adult Focal Spasticity in the United Kingdom. | NeuroRehabilitation | 2025 | https://conductscience.org/library/papers/40442021 | PubMed |
| 40423340 | Botulinum Toxin in Pain-Related Post-Stroke Limb Spasticity: A Meta-Analysis of Early and Late Injections. | Toxins (Basel) | 2025 | https://conductscience.org/library/papers/40423340 | PubMed |
| 39629752 | Clinical Outcome Assessments for Spasticity: Review, Critique, and Recommendations. | Mov Disord | 2025 | https://conductscience.org/library/papers/39629752 | PubMed |
| 39330846 | Do Diagnostic Nerve Blocks Affect the Starting Dose of Botulinum Neurotoxin Type A for Spasticity? A Case-Control Study. | Toxins (Basel) | 2024 | https://conductscience.org/library/papers/39330846 | PubMed |
| 39195750 | Botulinum Toxin Type A (BoNT-A) Use for Post-Stroke Spasticity: A Multicenter Study Using Natural Language Processing and Machine Learning. | Toxins (Basel) | 2024 | https://conductscience.org/library/papers/39195750 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34608495
GET https://conductscience.org/api/papers/v1/34608495/references?page=2